Search -

Displaying 881 - 900 of 2765

Sort: Relevancy | Date

News Opinion Off Script TCT 2019

Off Script: The New Gatekeepers of Procedural Education

Kwan S. Lee

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Presenter: Michael Mack

September 27, 2019

Presentation TCT 2019

Regulatory Considerations for New Valves and Adjunctive Devices

Presenter: Jennifer Bastijanic

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Presenter: Changfu Wu

September 27, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Presenter: Ted Feldman

September 27, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Presenter: Adrian Magee

September 27, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

Reimbursement Pathways for Shock Devices

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Presentation TCT 2019

Devices to Treat Shock: Regulatory Perspectives

Presenter: Fernando Aguel

September 27, 2019

Presentation TCT 2019

Perspectives on Infarct Size as a Surrogate in STEMI

Presenter: Navin Kapur

September 27, 2019

Presentation TCT 2019

Industry View on Controlled Trials for Heart Failure and Shock Devices

Presenter: William Abraham

September 27, 2019

Presentation TCT 2019

ARC Initiative for Heart Failure and Shock: HF ARC, Shock ARC, and More

Presenter: Christopher O'Connor

September 27, 2019

Advertisement

Off Script: The New Gatekeepers of Procedural Education

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

TAVR for Aortic Regurgitation: Clinical Device Evaluation Considerations

TAVR for Bicuspid Aortic Stenosis: What Is Known and What Is Not

Regulatory Considerations for New Valves and Adjunctive Devices

Transcatheter Mitral Valve Repair and Replacement Devices: Reimbursement Considerations

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Regulatory Considerations

Transcatheter Mitral Valve Repair and Replacement Pivotal Trials: Industry Perspectives

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Regulatory Considerations for High Bleeding Risk Patients Undergoing PCI

Defining High Bleeding Risk: HBR ARC

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Reimbursement Pathways for Shock Devices

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Industry Perspectives on Controlled Trials for Shock Devices

Devices to Treat Shock: Regulatory Perspectives

Perspectives on Infarct Size as a Surrogate in STEMI

Industry View on Controlled Trials for Heart Failure and Shock Devices

ARC Initiative for Heart Failure and Shock: HF ARC, Shock ARC, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content